Breast Cancer Clinical Trial Targets Cancer Stem CellsA major reason that breast cancer returns after treatment and spreads to other parts of the body is that current chemotherapy and radiation treatments do not kill the cancer stem cells. That premise provides the basis for a clinical trial open at the University of Michigan Comprehensive Cancer Center and two other sites testing a drug that has been found in laboratory studies to attack cancer stem cells.
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen